PEAPACK, NJ-Jeffrey Dunne, Kevin Welsh and Christopher Leonard of CB Richard Ellis' New York Institutional Group teamed with Bill Moylan of the CBRE Boston office to represent the seller in the $23-million sale of the leasehold interest in 100 Rt. 206 N. here. The seller was Hamilton Associates Limited Partnership and the purchaser was Pharmacia & Upjohn Company LLC, an entity controlled by Pfizer, Inc.
The assets are located approximately three miles north of Exit 22 of Interstate 287 and encompass 10 office buildings--totaling 518,000 square feet--interconnected by above ground and underground walkways. The buildings, which are situated within a 70-acre campus setting, were constructed in 1982 as a campus for Beneficial Management, then a national finance company.
Beneficial did a sale-leaseback in 1982 and subsequently sublet the entire campus to Pharmacia & Upjohn. Pfizer, through its acquisition of Pharmacia & Upjohn, currently occupies the buildings and will consolidate various operations into the property from throughout the region. Pfizer is also the owner of the fee interest.
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.